1 follower
Pneumagen develops glycan targeted carbohydrate binding modules (CBMs) for respiratory tract infections ) and cancer.
Douglas Thomson
QuellTX
4 followers
Avalere Health
3 followers
Agilix Health
2 followers
Oxford Nanopore Technologies
7 followers
PureGym
5 followers
Gold Care Homes
1 follower
Genomics England
3 followers
Johnson & Johnson
441 followers
Oxford BioMedica
2 followers
Manual
2 followers
FUJIFILM Diosynth Biotechnologies
5 followers
Explore companies